Achillion Pharmaceuticals, Inc. (ACHN)
Healthcare: Biotechnology
Schedule 13D and 13G filings submitted since 09/30/2011
| Filing Company | Date of Filing |
Total Reported Shares Owned |
Shares Reported on 13F |
|
|---|---|---|---|---|
| SC 13D | XMARK OPPORTUNITY PARTNERS, LLC | 06/30/2008 | 923,068 | 0 |
| SC 13D | XMARK OPPORTUNITY PARTNERS, LLC | 06/30/2008 | 923,068 | 0 |
| SC 13D/A | XMARK OPPORTUNITY PARTNERS, LLC | 07/18/2008 | 874,068 | 0 |
| SC 13D/A | XMARK OPPORTUNITY PARTNERS, LLC | 07/18/2008 | 874,068 | 0 |
*Shares are split adjusted
